A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
Clinical trial NCT06640049 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06640049
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-17
- Primary completion
- 2027-10-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.